B3 SA - Brasil Bolsa Balcao

B3SA3
stockFinancial ServicesFinancial Exchanges & Data
$6/day into B3SA3 since 2015 would be worth $41,361 today — 2.4× the money.
Try your own number →

B3 S.A. - Brasil, Bolsa, Balcão, a financial market infrastructure company, provides trading services in an exchange and OTC environment. It operates through Markets, Data analytics solutions, Capital Market solutions, and Technology and platform segments. The company organized markets for securities, such as equities, financial contracts, indices, rates, currencies, energy, transportation, commodities, and spot and future settlement transactions. It also provides technological solutions for insurance, reinsurance, pension, and capitalization bond markets; data processing and analytics services, including standardization, quotations, and statistics; supports credit, financing, and leasing transactions in automotive, real estate, energy, and agribusiness sectors; and operates trading systems and clearinghouses. In addition, the company organized an over-the-counter market, and acts as a clearing ang settlement house. The company was formerly known as BM&FBOVESPA S.A. - Bolsa de Valores, Mercadorias e Futuros and changed its name to B3 S.A. - Brasil, Bolsa, Balcão in June 2017. B3 S.A. - Brasil, Bolsa, Balcão was incorporated in 2007 and is headquartered in São Paulo, Brazil.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of B3SA3-SA would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2007) — listing
$94,008
3.4×
$138,740
3.4×
Year 6 (2012)
$71,843
3.3×
$106,129
3.4×
Year 11 (2017)
$24,674
1.8×
$36,253
1.8×
Year 16 (2022)
$9,293
1.4×
$13,624
1.4×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with B3SA3

For illustration only — not investment advice. Past performance is not indicative of future results.